InvestorsHub Logo
Followers 9
Posts 1541
Boards Moderated 0
Alias Born 09/14/2016

Re: None

Thursday, 07/27/2017 12:28:09 AM

Thursday, July 27, 2017 12:28:09 AM

Post# of 672
Will the adcomm vote against IPCI's Rexista help EGLT? Does not look good for FDA approval anymore since the committee voted overwhelmingly NO. I picked up some when i looked bad for IPCI and hoping I will get some money back via EGLT. I need to rode it to $4/share, I hope we can do that in a year. Just wondering what people think because it doesn't look good for anymore players in this field of opioids to get approved anytime soon.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.